Bánfi-Bacsárdi, F.; Kazay, Á.; Gergely, T.G.; Forrai, Z.; Füzesi, T.P.; Hanuska, L.F.; Schäffer, P.P.; Pilecky, D.; Vámos, M.; Vértes, V.;
et al. Therapeutic Consequences and Prognostic Impact of Multimorbidity in Heart Failure: Time to Act. J. Clin. Med. 2025, 14, 139.
https://doi.org/10.3390/jcm14010139
AMA Style
Bánfi-Bacsárdi F, Kazay Á, Gergely TG, Forrai Z, Füzesi TP, Hanuska LF, Schäffer PP, Pilecky D, Vámos M, Vértes V,
et al. Therapeutic Consequences and Prognostic Impact of Multimorbidity in Heart Failure: Time to Act. Journal of Clinical Medicine. 2025; 14(1):139.
https://doi.org/10.3390/jcm14010139
Chicago/Turabian Style
Bánfi-Bacsárdi, Fanni, Ádám Kazay, Tamás G. Gergely, Zsolt Forrai, Tamás Péter Füzesi, Laura Fanni Hanuska, Pál Péter Schäffer, Dávid Pilecky, Máté Vámos, Vivien Vértes,
and et al. 2025. "Therapeutic Consequences and Prognostic Impact of Multimorbidity in Heart Failure: Time to Act" Journal of Clinical Medicine 14, no. 1: 139.
https://doi.org/10.3390/jcm14010139
APA Style
Bánfi-Bacsárdi, F., Kazay, Á., Gergely, T. G., Forrai, Z., Füzesi, T. P., Hanuska, L. F., Schäffer, P. P., Pilecky, D., Vámos, M., Vértes, V., Dékány, M., Andréka, P., Piróth, Z., Nyolczas, N., & Muk, B.
(2025). Therapeutic Consequences and Prognostic Impact of Multimorbidity in Heart Failure: Time to Act. Journal of Clinical Medicine, 14(1), 139.
https://doi.org/10.3390/jcm14010139